Picture of mobile phone running fintech app

Fintech: Open Access research exploring new frontiers in financial technology

Strathprints makes available Open Access scholarly outputs by the Department of Accounting & Finance at Strathclyde. Particular research specialisms include financial risk management and investment strategies.

The Department also hosts the Centre for Financial Regulation and Innovation (CeFRI), demonstrating research expertise in fintech and capital markets. It also aims to provide a strategic link between academia, policy-makers, regulators and other financial industry participants.

Explore all Strathclyde Open Access research...

Browse by Author or Creator

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item type | No Grouping
Jump to: Article
Number of items: 7.

Article

Lumb, Felicity E. and Doonan, James and Bell, Kara S. and Pineda, Miguel A. and Corbet, Marlene and Suckling, Colin J. and Harnett, Margaret M. and Harnett, William (2017) Dendritic cells provide a therapeutic target for synthetic small molecule analogues of the parasitic worm product, ES-62. Scientific Reports. ISSN 2045-2322

Crowe, Jenny and Lumb, Felicity E. and Harnett, Margaret M. and Harnett, William (2017) Parasite excretory-secretory products and their effects on metabolic syndrome. Parasite Immunology. ISSN 0141-9838

Janicova, L. and Rzepecka, J. and Rodgers, D.T. and Doonan, J and Bell, K. and Lumb, F.E. and Suckling, C.J. and Harnett, M.M. and Harnett, W. (2016) Testing small molecule analogues of acanthocheilonema viteae immunomodulator ES-62 against clinically relevant allergens. Parasite Immunology, 38 (6). pp. 340-351. ISSN 0141-9838

Bell, Kara S. and Al-Riyami, Lamyaa and Lumb, Felicity E. and Britton, Graham J. and Poole, Alastair W. and Williams, Chris M. and Braun, Ursula and Leitges, Michael and Harnett, Margaret M. and Harnett, William (2015) The role of individual protein kinase C isoforms in mouse mast cell function and their targeting by the immunomodulatory parasitic worm product, ES-62. Immunology Letters, 168 (1). pp. 31-40. ISSN 0165-2478

Rzepecka, Justyna and Pineda, Miguel A. and Al-Riyami, Lamyaa and Rodgers, David T. and Huggan, Judith K. and Lumb, Felicity E. and Khalaf, Abedawn I. and Meakin, Paul J. and Corbet, Marlene and Ashford, Michael L. and Suckling, Colin J. and Harnett, Margaret M. and Harnett, William (2015) Prophylactic and therapeutic treatment with a synthetic analogue of a parasitic worm product prevents experimental arthritis and inhibits IL-1β production via NRF2-mediated counter-regulation of the inflammasome. Journal of Autoimmunity, 60. pp. 59-73. ISSN 0896-8411

Rodgers, David T. and McGrath, Mairi A. and Pineda, Miguel A. and Al-Riyami, Lamyaa and Rzepecka, Justyna and Lumb, Felicity and Harnett, William and Harnett, Margaret M. (2015) The parasitic worm product ES-62 targets myeloid differentiation factor 88-dependent effector mechanisms to suppress antinuclear antibody production and proteinuria in MRL/lpr mice. Arthritis and Rheumatology, 67 (4). pp. 1023-1035. ISSN 2326-5205

Pineda, Miguel A. and Lumb, Felicity and Harnett, Margaret M. and Harnett, William (2014) ES-62, a therapeutic anti-inflammatory agent evolved by the filarial nematode Acanthocheilonema viteae. Molecular and Biochemical Parasitology, 194 (1-2). pp. 1-8. ISSN 0166-6851

This list was generated on Sun Feb 18 16:43:35 2018 GMT.